Taro Pharmaceutical Says It Is Company's Policy Not to Comment on Market Activity

Taro Pharmaceutical Industries Ltd.

, today announced that in view of the unusual market activity in the Company's stock, the New York Stock Exchange has contacted the Company in accordance with its usual practice. The NYSE has asked the Company to respond by press release to the unusual activity. The Company's policy is not to comment on unusual market activity, rumors or speculation.